Incidence of adverse events of concomitant immune checkpoint inhibitors and ultra hypo-fractionated radiotherapy: systematic review and meta-analysis.

Spindler NJ, Eefsen RL, Persson GF, Nielsen DL, Juhl CB

Open source

DOI
10.1016/j.ctro.2026.101328
Published
2027 Jan
Container
Clinical and translational radiation oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctro.2026.101328,
  title = {Incidence of adverse events of concomitant immune checkpoint inhibitors and ultra hypo-fractionated radiotherapy: systematic review and meta-analysis.},
  author = {Spindler NJ and Eefsen RL and Persson GF and Nielsen DL and Juhl CB},
  year = {2027},
  journal = {Clinical and translational radiation oncology},
  doi = {10.1016/j.ctro.2026.101328},
  url = {https://doi.org/10.1016/j.ctro.2026.101328}
}

RIS

TY  - JOUR
TI  - Incidence of adverse events of concomitant immune checkpoint inhibitors and ultra hypo-fractionated radiotherapy: systematic review and meta-analysis.
AU  - Spindler NJ
AU  - Eefsen RL
AU  - Persson GF
AU  - Nielsen DL
AU  - Juhl CB
PY  - 2027
JO  - Clinical and translational radiation oncology
DO  - 10.1016/j.ctro.2026.101328
UR  - https://doi.org/10.1016/j.ctro.2026.101328
ER  - 

APA

NJ, S., RL, E., GF, P., DL, N., & CB, J. (2027). Incidence of adverse events of concomitant immune checkpoint inhibitors and ultra hypo-fractionated radiotherapy: systematic review and meta-analysis.. Clinical and translational radiation oncology. https://doi.org/10.1016/j.ctro.2026.101328

Source records